<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardio</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиология</journal-title><trans-title-group xml:lang="en"><trans-title>Kardiologiia</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0022-9040</issn><issn pub-type="epub">2412-5660</issn><publisher><publisher-name>Kardiomag</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18087/cardio.2022.1.n1777</article-id><article-id custom-type="elpub" pub-id-type="custom">cardio-1777</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>RESEARCH ARTICLES</subject></subj-group></article-categories><title-group><article-title>Предикторы возникновения фибрилляции предсердий у пациентов с ишемическим инсультом неопределенной этиологии</article-title><trans-title-group xml:lang="en"><trans-title>Predictors of atrial fibrillation in patients with ischemic stroke of undetermined etiology</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9011-2879</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рахимова</surname><given-names>И. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Rakhimova</surname><given-names>I. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ассистент кафедры</p></bio><bio xml:lang="en"><p>department assistant</p></bio><email xlink:type="simple">idalya111@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1886-0538</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хайбуллин</surname><given-names>Т. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Khaibullin</surname><given-names>T. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>профессор кафедры неврологии, офтальмологии и отоларингологии, д.м.н., профессор</p></bio><bio xml:lang="en"><p>professor, M.D.,  Ph.D.</p></bio><email xlink:type="simple">htn2006@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1004-2162</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ковальчук</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kovalchuk</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>заведующий отделением реабилитации пациентов с нарушением функций ЦНС, профессор Кембриджского Университета, д.м.н., профессор</p></bio><bio xml:lang="en"><p>professor, M.D.,  Ph.D.</p></bio><email xlink:type="simple">vikoval67@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1324-7806</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Семенова</surname><given-names>Ю. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Semenova</surname><given-names>Yu. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>заведующая кафедрой неврологии, офтальмологии и отоларингологии, к.м.н., профессор</p></bio><bio xml:lang="en"><p>professor, M.D.,  Ph.D.</p></bio><email xlink:type="simple">yumsem@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6315-5016</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Абдрахманов</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Abdrakhmanov</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>заведующий отделением интервенционной аритмологии, д.м.н., профессор</p></bio><bio xml:lang="en"><p>professor, M.D.,  Ph.D.</p></bio><email xlink:type="simple">ayan-3@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>НАО Медицинский университет Семей, г. Семей, Казахстан</institution><country>Казахстан</country></aff><aff xml:lang="en"><institution>NJSC Semey Medical University, Semey, Kazakhstan</institution><country>Kazakhstan</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Кембриджский университет, Кембридж, Великобритания</institution><country>Великобритания</country></aff><aff xml:lang="en"><institution>University of Cambridge, Cambridge, Great Britain</institution><country>United Kingdom</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Национальный научный кардиохирургический центр, Нур-Султан, Казахстан</institution><country>Казахстан</country></aff><aff xml:lang="en"><institution>National research cardiac surgery center, Nur-Sultan, Kazakhstan</institution><country>Kazakhstan</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>31</day><month>01</month><year>2022</year></pub-date><volume>62</volume><issue>1</issue><fpage>40</fpage><lpage>45</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Kardiomag, 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Kardiomag</copyright-holder><copyright-holder xml:lang="en">Kardiomag</copyright-holder><license xlink:href="https://cardio.elpub.ru/jour/about/submissions#copyrightNotice" xlink:type="simple"><license-p>https://cardio.elpub.ru/jour/about/submissions#copyrightNotice</license-p></license></permissions><self-uri xlink:href="https://cardio.elpub.ru/jour/article/view/1777">https://cardio.elpub.ru/jour/article/view/1777</self-uri><abstract><p>Цель    Определение комплекса предикторов и создание математической модели прогнозирования возникновения фибрилляции предсердий (ФП) у пациентов с ишемическим инсультом неопределенной этиологии.Материал и методы    В исследование включен 981 пациент с ишемическим инсультом. Рассматривалось влияние следующих факторов: пол, наличие инсульта в анамнезе, наличие тромбоэмболии в анамнезе, наличие сахарного диабета, степень артериальной гипертензии, функциональный класс (ФК) хронической сердечной недостаточности (ХСН), возраст, данные биохимического анализа крови, данные коагулограммы. При построении прогностической модели была использована бинарная логистическая регрессия. Рассчитано значение площади под ROC-кривой для предложенной прогностической модели.Результаты    Основными предикторами развития ФП у пациентов с ишемическим инсультом неопределенной этиологии явились: ФК ХСН, инсульт в анамнезе, возраст, пол, уровень холестерина и протромбиновый индекс, которые вошли в итоговую прогностическую модель. Чувствительность разработанной модели составила 83,5 %, специфичность – 85,5 %. Площадь под ROC-кривой, соответствующей взаимосвязи прогноза фибрилляции предсердий и значения регрессионной функции, составила 0,921±0,012 с 95 % доверительным интервалом: 0,898–0,944.Заключение    Согласно полученным данным, вероятность наличия ФП у пациентов с ишемическим инсультом увеличивалась при прогрессировании ХСН, повторном инсульте, увеличении возраста, принадлежности к женскому полу, а также при снижении протромбинового индекса и уровня холестерина.</p></abstract><trans-abstract xml:lang="en"><p>Aim    To identify a complex of predictors and to create a mathematical model for prognosis of atrial fibrillation (AF) in patients with ischemic stroke of undetermined etiology. Material and methods    The study included 981 patients with ischemic stroke. Effects of the following factors were evaluated: gender, a history of stroke, a history of thromboembolism, presence of diabetes mellitus, grade of arterial hypertension, functional class (FC) of chronic heart failure (CHF), age, data of blood biochemistry, and data of coagulogram. The prognostic model was constructed using the binary logistic regression. The value of area under the ROC curve for the proposed prognostic model was calculated.Results    The main predictors of AF in patients with ischemic stroke of undetermined etiology were CHF FC, a history of stroke, age, gender, values of cholesterol and prothrombin index, which were included into the final prognostic model. The sensitivity of the developed model was 83.5 % and the specificity was 85.5 %. The area under the ROC curve corresponding to the interrelation between the prognosis of AF and the regression function value was 0.921±0.012 with 95 % confidence interval: 0.898–0.944.Conclusion    According to the results of the study, the probability of AF in patients with ischemic stroke increased with CHF progression, recurrent stroke, older age, female gender, and reduced prothrombin index and cholesterol level.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>Фибрилляция предсердий</kwd><kwd>инсульт неопределенной этиологии</kwd><kwd>криптогенный инсульт</kwd><kwd>модель прогнозирования</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Atrial fibrillation</kwd><kwd>stroke of undetermined etiology</kwd><kwd>cryptogenic stroke</kwd><kwd>prognostic model</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Конфликт интересов не заявлен.</funding-statement><funding-statement xml:lang="en">No conflict of interest is reported.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Feigin VL, Brainin M, Norrving B, Martins S, Sacco RL, Hacke W et al. World Stroke Organization (WSO): Global Stroke Fact Sheet 2022. International Journal of Stroke. 2022;17(1):18–29. DOI: 10.1177/17474930211065917</mixed-citation><mixed-citation xml:lang="en">Feigin VL, Brainin M, Norrving B, Martins S, Sacco RL, Hacke W et al. World Stroke Organization (WSO): Global Stroke Fact Sheet 2022. International Journal of Stroke. 2022;17(1):18–29. DOI: 10.1177/17474930211065917</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Kim J, Thayabaranathan T, Donnan GA, Howard G, Howard VJ, Rothwell PM et al. Global Stroke Statistics 2019. International Journal of Stroke. 2020;15(8):819–38. DOI: 10.1177/1747493020909545</mixed-citation><mixed-citation xml:lang="en">Feigin VL, Brainin M, Norrving B, Martins S, Sacco RL, Hacke W et al. World Stroke Organization (WSO): Global Stroke Fact Sheet 2022. International Journal of Stroke. 2022;17(1):18–29. DOI: 10.1177/17474930211065917</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Krishnamurthi RV, Moran AE, Feigin VL, Barker-Collo S, Norrving B, Mensah GA et al. Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Adults Aged 20-64 Years in 1990-2013: Data from the Global Burden of Disease 2013 Study. Neuroepidemiology. 2015;45(3):190–202. DOI: 10.1159/000441098</mixed-citation><mixed-citation xml:lang="en">Kim J, Thayabaranathan T, Donnan GA, Howard G, Howard VJ, Rothwell PM et al. Global Stroke Statistics 2019. International Journal of Stroke. 2020;15(8):819–38. DOI: 10.1177/1747493020909545</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Chong JY, Sacco RL. Epidemiology of Stroke in Young Adults: Race/Ethnic Differences. Journal of Thrombosis and Thrombolysis. 2005;20(2):77–83. DOI: 10.1007/s11239-005-3201-9</mixed-citation><mixed-citation xml:lang="en">Krishnamurthi RV, Moran AE, Feigin VL, Barker-Collo S, Norrving B, Mensah GA et al. Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Adults Aged 20-64 Years in 1990-2013: Data from the Global Burden of Disease 2013 Study. Neuroepidemiology. 2015;45(3):190–202. DOI: 10.1159/000441098</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Thrift AG, Thayabaranathan T, Howard G, Howard VJ, Rothwell PM, Feigin VL et al. Global stroke statistics. International Journal of Stroke. 2017;12(1):13–32. DOI: 10.1177/1747493016676285</mixed-citation><mixed-citation xml:lang="en">Chong JY, Sacco RL. Epidemiology of Stroke in Young Adults: Race/Ethnic Differences. Journal of Thrombosis and Thrombolysis. 2005;20(2):77–83. DOI: 10.1007/s11239-005-3201-9</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Министерство Здравоохранения Республики Казахстан. Здоровье населения Республики Казахстан и деятельность организаций здравоохранения в 2014-2018гг. Статистические сборники. Доступно на: http://www.rcrz.kz/index.php/ru/statistika-zdravookhraneniya-2</mixed-citation><mixed-citation xml:lang="en">Thrift AG, Thayabaranathan T, Howard G, Howard VJ, Rothwell PM, Feigin VL et al. Global stroke statistics. International Journal of Stroke. 2017;12(1):13–32. DOI: 10.1177/1747493016676285</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP et al. Heart Disease and Stroke Statistics–2020 Update: A Report From the American Heart Association. Circulation. 2020;141(9):e139–596. DOI: 10.1161/CIR.0000000000000757</mixed-citation><mixed-citation xml:lang="en">Ministry of Health of the Republic of Kazakhstan. The health of the population of the Republic of Kazakhstan and the activities of healthcare organizations in 2014-2018. Statistical collections. Av. at: http://www.rcrz.kz/index.php/ru/statistika-zdravookhraneniya-2.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Fonseca AC, Ferro JM. Cryptogenic stroke. European Journal of Neurology. 2015;22(4):618–23. DOI: 10.1111/ene.12673</mixed-citation><mixed-citation xml:lang="en">Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP et al. Heart Disease and Stroke Statistics–2020 Update: A Report From the American Heart Association. Circulation. 2020;141(9):e139–596. DOI: 10.1161/CIR.0000000000000757</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Watson T, Shantsila E, Lip GYH. Mechanisms of thrombogenesis in atrial fibrillation: Virchow’s triad revisited. The Lancet. 2009;373(9658):155–66. DOI: 10.1016/S0140-6736(09)60040-4</mixed-citation><mixed-citation xml:lang="en">Fonseca AC, Ferro JM. Cryptogenic stroke. European Journal of Neurology. 2015;22(4):618–23. DOI: 10.1111/ene.12673</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22(8):983–8. DOI: 10.1161/01.STR.22.8.983</mixed-citation><mixed-citation xml:lang="en">Watson T, Shantsila E, Lip GYH. Mechanisms of thrombogenesis in atrial fibrillation: Virchow’s triad revisited. The Lancet. 2009;373(9658):155–66. DOI: 10.1016/S0140-6736(09)60040-4</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Shafqat S, Kelly PJ, Furie KL. Holter monitoring in the diagnosis of stroke mechanism: Holter monitoring in stroke. Internal Medicine Journal. 2004;34(6):305–9. DOI: 10.1111/j.1444-0903.2004.00589.x</mixed-citation><mixed-citation xml:lang="en">Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22(8):983–8. DOI: 10.1161/01.STR.22.8.983</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Schuchert A, Behrens G, Meinertz T. Impact of Long-Term ECG Recording on the Detection of Paroxysmal Atrial Fibrillation in Patients After an Acute Ischemic Stroke. Pacing and Clinical Electrophysiology. 1999;22(7):1082–4. DOI: 10.1111/j.1540-8159.1999.tb00574.x</mixed-citation><mixed-citation xml:lang="en">Shafqat S, Kelly PJ, Furie KL. Holter monitoring in the diagnosis of stroke mechanism: Holter monitoring in stroke. Internal Medicine Journal. 2004;34(6):305–9. DOI: 10.1111/j.1444-0903.2004.00589.x</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Jabaudon D, Sztajzel J, Sievert K, Landis T, Sztajzel R. Usefulness of Ambulatory 7-Day ECG Monitoring for the Detection of Atrial Fibrillation and Flutter After Acute Stroke and Transient Ischemic Attack. Stroke. 2004;35(7):1647–51. DOI: 10.1161/01.STR.0000131269.69502.d9</mixed-citation><mixed-citation xml:lang="en">Schuchert A, Behrens G, Meinertz T. Impact of Long-Term ECG Recording on the Detection of Paroxysmal Atrial Fibrillation in Patients After an Acute Ischemic Stroke. Pacing and Clinical Electrophysiology. 1999;22(7):1082–4. DOI: 10.1111/j.1540-8159.1999.tb00574.x</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Pecha S, Wilke I, Yildirim Y, Reichenspurner H, Aydin MA. Implantable loop recorder monitoring in patients with cryptogenic stroke - Detection and treatment of different clinically relevant arrhythmias. Journal of Electrocardiology. 2020; 60:102–6. DOI: 10.1016/j.jelectrocard.2020.04.007</mixed-citation><mixed-citation xml:lang="en">Jabaudon D, Sztajzel J, Sievert K, Landis T, Sztajzel R. Usefulness of Ambulatory 7-Day ECG Monitoring for the Detection of Atrial Fibrillation and Flutter After Acute Stroke and Transient Ischemic Attack. Stroke. 2004;35(7):1647–51. DOI: 10.1161/01.STR.0000131269.69502.d9</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Poli S, Diedler J, Härtig F, Götz N, Bauer A, Sachse T et al. Insertable cardiac monitors after cryptogenic stroke - a risk factor based approach to enhance the detection rate for paroxysmal atrial fibrillation. European Journal of Neurology. 2016;23(2):375–81. DOI: 10.1111/ene.12843</mixed-citation><mixed-citation xml:lang="en">Pecha S, Wilke I, Yildirim Y, Reichenspurner H, Aydin MA. Implantable loop recorder monitoring in patients with cryptogenic stroke - Detection and treatment of different clinically relevant arrhythmias. Journal of Electrocardiology. 2020; 60:102–6. DOI: 10.1016/j.jelectrocard.2020.04.007</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Клинический протокол диагностики и лечения. Ишемический инсульт. 2016. Доступно на: http://www.rcrz.kz/docs/clinic_protocol/2016/2пг/Терапия/Невропатология/8Ишемическийинсульт.pdf</mixed-citation><mixed-citation xml:lang="en">Poli S, Diedler J, Härtig F, Götz N, Bauer A, Sachse T et al. Insertable cardiac monitors after cryptogenic stroke - a risk factor based approach to enhance the detection rate for paroxysmal atrial fibrillation. European Journal of Neurology. 2016;23(2):375–81. DOI: 10.1111/ene.12843</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">2018 ESC/ESH Guidelines for the management of arterial hypertension. Revista Española de Cardiología (English Edition). 2019;72(2):160. DOI: 10.1016/j.rec.2018.12.004</mixed-citation><mixed-citation xml:lang="en">Clinical protocol of diagnosis and treatment. Ischemic stroke. 2016. Av. at: http://www.rcrz.kz/docs/clinic_protocol/2016/2пг/Терапия/Невропатология/8Ишемическийинсульт.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Van der Meer P, Gaggin HK, Dec GW. ACC/AHA Versus ESC Guidelines on Heart Failure. Journal of the American College of Cardiology. 2019;73(21):2756–68. DOI: 10.1016/j.jacc.2019.03.478</mixed-citation><mixed-citation xml:lang="en">2018 ESC/ESH Guidelines for the management of arterial hypertension. Revista Española de Cardiología (English Edition). 2019;72(2):160. DOI: 10.1016/j.rec.2018.12.004</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">International Diabetes Federation Guideline Development Group. Global Guideline for Type 2 Diabetes. Diabetes Research and Clinical Practice. 2014;104(1):1–52. DOI: 10.1016/j.diabres.2012.10.001</mixed-citation><mixed-citation xml:lang="en">Van der Meer P, Gaggin HK, Dec GW. ACC/AHA Versus ESC Guidelines on Heart Failure. Journal of the American College of Cardiology. 2019;73(21):2756–68. DOI: 10.1016/j.jacc.2019.03.478</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. European Heart Journal. 2016;37(38):2893–962. DOI: 10.1093/eurheartj/ehw210</mixed-citation><mixed-citation xml:lang="en">International Diabetes Federation Guideline Development Group. Global Guideline for Type 2 Diabetes. Diabetes Research and Clinical Practice. 2014;104(1):1–52. DOI: 10.1016/j.diabres.2012.10.001</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Riordan M, Opaskar A, Yoruk A, Younis A, Ali A, McNitt S et al. Predictors of Atrial Fibrillation During Long‐Term Implantable Cardiac Monitoring Following Cryptogenic Stroke. Journal of the American Heart Association. 2020;9(15). DOI: 10.1161/JAHA.120.016040</mixed-citation><mixed-citation xml:lang="en">Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. European Heart Journal. 2016;37(38):2893–962. DOI: 10.1093/eurheartj/ehw210</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Börschel CS, Ohlrogge AH, Geelhoed B, Niiranen T, Havulinna AS, Palosaari T et al. Risk prediction of atrial fibrillation in the community combining biomarkers and genetics. EP Europace. 2021;23(5):674– 81. DOI: 10.1093/europace/euaa334</mixed-citation><mixed-citation xml:lang="en">Riordan M, Opaskar A, Yoruk A, Younis A, Ali A, McNitt S et al. Predictors of Atrial Fibrillation During Long‐Term Implantable Cardiac Monitoring Following Cryptogenic Stroke. Journal of the American Heart Association. 2020;9(15). DOI: 10.1161/JAHA.120.016040</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Tsioufis C, Konstantinidis D, Nikolakopoulos I, Vemmou E, Kalos T, Georgiopoulos G et al. Biomarkers of Atrial Fibrillation in Hypertension. Current Medicinal Chemistry. 2019;26(5):888–97. DOI: 10.2174/0929867324666171006155516</mixed-citation><mixed-citation xml:lang="en">Börschel CS, Ohlrogge AH, Geelhoed B, Niiranen T, Havulinna AS, Palosaari T et al. Risk prediction of atrial fibrillation in the community combining biomarkers and genetics. EP Europace. 2021;23(5):674– 81. DOI: 10.1093/europace/euaa334</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Westerman S, Wenger N. Gender Differences in Atrial Fibrillation: A Review of Epidemiology, Management, and Outcomes. Current Cardiology Reviews. 2019;15(2):136–44. DOI: 10.2174/1573403X15666181205110624</mixed-citation><mixed-citation xml:lang="en">Tsioufis C, Konstantinidis D, Nikolakopoulos I, Vemmou E, Kalos T, Georgiopoulos G et al. Biomarkers of Atrial Fibrillation in Hypertension. Current Medicinal Chemistry. 2019;26(5):888–97. DOI: 10.2174/0929867324666171006155516</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Wu Y, Xie Z, Liang W, Xue R, Wu Z, Wu D et al. Usefulness of CHADS2, R2CHADS2, and CHA2DS2‐VASc scores for predicting incident atrial fibrillation in heart failure with preserved ejection fraction patients. ESC Heart Failure. 2021;8(2):1369–77. DOI: 10.1002/ ehf2.13217</mixed-citation><mixed-citation xml:lang="en">Westerman S, Wenger N. Gender Differences in Atrial Fibrillation: A Review of Epidemiology, Management, and Outcomes. Current Cardiology Reviews. 2019;15(2):136–44. DOI: 10.2174/1573403X15666181205110624</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Mazaris S, Siasos G, Oikonomou E, Tsigkou V, Vavuranakis M, Kokkou E et al. Atrial Fibrillation: Biomarkers Determining Prognosis. Current Medicinal Chemistry. 2019;26(5):909–15. DOI: 10.2174/0929867324666170727115642</mixed-citation><mixed-citation xml:lang="en">Wu Y, Xie Z, Liang W, Xue R, Wu Z, Wu D et al. Usefulness of CHADS2, R2CHADS2, and CHA2DS2‐VASc scores for predicting incident atrial fibrillation in heart failure with preserved ejection fraction patients. ESC Heart Failure. 2021;8(2):1369–77. DOI: 10.1002/ ehf2.13217</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Aydin M, Susam I, Kilicaslan B, Dereli M, Sacar M, Ozdogan O. Serum cholesterol levels and postoperative atrial fibrillation. Journal of Cardiothoracic Surgery. 2014;9(1):69. DOI: 10.1186/1749-8090-9-69</mixed-citation><mixed-citation xml:lang="en">Mazaris S, Siasos G, Oikonomou E, Tsigkou V, Vavuranakis M, Kokkou E et al. Atrial Fibrillation: Biomarkers Determining Prognosis. Current Medicinal Chemistry. 2019;26(5):909–15. DOI: 10.2174/0929867324666170727115642</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Magnussen C, Niiranen TJ, Ojeda FM, Gianfagna F, Blankenberg S, Njølstad I et al. Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results from the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe). Circulation. 2017;136(17):1588– 97. DOI: 10.1161/CIRCULATIONAHA.117.028981</mixed-citation><mixed-citation xml:lang="en">Aydin M, Susam I, Kilicaslan B, Dereli M, Sacar M, Ozdogan O. Serum cholesterol levels and postoperative atrial fibrillation. Journal of Cardiothoracic Surgery. 2014;9(1):69. DOI: 10.1186/1749-8090-9-69</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Mora S, Akinkuolie AO, Sandhu RK, Conen D, Albert CM. Paradoxical Association of Lipoprotein Measures with Incident Atrial Fibrillation. Circulation: Arrhythmia and Electrophysiology. 2014;7(4):612– 9. DOI: 10.1161/CIRCEP.113.001378</mixed-citation><mixed-citation xml:lang="en">Magnussen C, Niiranen TJ, Ojeda FM, Gianfagna F, Blankenberg S, Njølstad I et al. Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results from the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe). Circulation. 2017;136(17):1588– 97. DOI: 10.1161/CIRCULATIONAHA.117.028981</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Татаринцева З. Г., Космачева Е. Д. Дислипидемия у пациентов с фибрилляцией предсердий на фоне острого коронарного синдрома по данным регистра Краснодарского края. Инновационная медицина Кубани. 2019; 3:19-24. DOI: 10.35401/2500-0268-2019-15-3-19-24</mixed-citation><mixed-citation xml:lang="en">Mora S, Akinkuolie AO, Sandhu RK, Conen D, Albert CM. Paradoxical Association of Lipoprotein Measures with Incident Atrial Fibrillation. Circulation: Arrhythmia and Electrophysiology. 2014;7(4):612– 9. DOI: 10.1161/CIRCEP.113.001378</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Tatarintseva Z.G., Kosmacheva E.D. Dyslipidemia in patients with atrial fibrillation on the background of acute coronary syndrome according to the register of the Krasnodar region. Innovative medicine of Kuban. 2019; 3:19–24. DOI: 10.35401/2500-0268-2019-15-3-19-24</mixed-citation><mixed-citation xml:lang="en">Tatarintseva Z.G., Kosmacheva E.D. Dyslipidemia in patients with atrial fibrillation on the background of acute coronary syndrome according to the register of the Krasnodar region. Innovative medicine of Kuban. 2019; 3:19–24. DOI: 10.35401/2500-0268-2019-15-3-19-24</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
